USSTOCK.TODAY
Market Closed
Log in Sign up

Royalty Pharma to Announce Third Quarter Results Before US Market Open on November 4

The Motley Fool +1 · ·by G4L

RPRX Royalty Pharma plc
$69.45 +0.99%
View chart & analysis →
  1. 1Royalty Pharma will announce its third quarter 2026 results before the US market opens on November 4.
  2. 2According to analyst forecasts, Royalty Pharma is expected to record an 8.7% revenue growth rate for the quarter ended September 30.
  3. 3Royalty Pharma is expected to have a 0 profit growth rate for the quarter ended September 30.

So what's the key point?

Royalty Pharma is announcing its third quarter results on November 4. Experts expect revenue to grow by 8.7% and profit growth to be zero.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Revolution Medicines Receives FDA Approval for Pancreatic Cancer Treatment, Raising Royalty Pharma Revenue Expectations The Motley Fool +1 · 2d agoRoyalty Pharma: A Dividend-Yield Stock for Investors Without Pharmaceutical Expertise The Motley Fool +1 · Oct 22Ingredion's Q2 adjusted operating profit falls 5%… maintains EPS guidance GuruFocus.com +1 · Aug 5
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news